Clinical Trial: Efficacy and Safety of Simultaneous Integrated Boost Radiotherapy in HR/VHR Prostate Cancer With EPLNI

U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07693075) titled 'Efficacy and Safety of Simultaneous Integrated Boost Radiotherapy in HR/VHR Prostate Cancer With EPLNI' on June 28.

Brief Summary: The aim of this study is to evaluate the efficacy and safety of hypofractionated simultaneous integrated boost volumetric arc radiation therapy (SIB - VMAT) for high-risk and very high-risk localized prostate cancer in terms of:

1. Acute and late gastrointestinal and genitourinary toxicities.

2. Evaluate the efficacy in terms of early bPFS.

3. Dosimetric evaluation in terms of target coverage and organs at risk sparing

Study Start Date: Aug. 01, 2025

Study Type: INTERVENTIONAL

Condition: Prostate ...